美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LeonaBio Inc

6.94

-0.3000-4.14%

成交量：4.62萬

成交額：32.38萬

市值：6,519.10萬

市盈率：-0.30

高：7.30

開：7.10

低：6.70

收：7.24

52周最高：14.21

52周最低：3.58

股本：939.35萬

流通股本：473.04萬

量比：1.35

換手率：0.98%

股息：- -

股息率：- -

每股收益(TTM):-23.0100

每股收益(LYR):-24.7000

淨資產收益率：-431.39%

總資產收益率：-74.07%

市淨率：1.94

市盈率(LYR):-0.28

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

LeonaBio完成拉索昔芬聯合阿貝西利III期ELAIN-3試驗第500例受試者入組——SEC文件披露

LeonaBio Inc預計Lasofoxifene三期試驗患者招募將於2026年第四季度完成，關鍵數據將於2027年下半年公布

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LONA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LONA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","market":"US","secType":"STK","nameCN":"LeonaBio Inc","latestPrice":6.94,"timestamp":1789584107248,"preClose":7.24,"halted":0,"volume":46174,"delay":0,"changeRate":-0.04143646408839777,"floatShares":4730400,"shares":9393514,"eps":-23.01,"marketStatus":"交易中","change":-0.3,"latestTime":"09-16 14:45:36 EDT","open":7.1,"high":7.3,"low":6.7,"amount":323830.61354500003,"amplitude":0.082873,"askPrice":7.1,"askSize":100,"bidPrice":6.81,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-23.01,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":7.24,"postHourTrading":{"tag":"盘后","latestPrice":7.24,"preClose":7.24,"latestTime":"17:35 EDT","volume":23,"amount":166.07,"timestamp":1789508123579,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.353486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","floatShares":4730400,"roa":"-74.07%","roe":"-431.39%","lyrEps":-24.699999,"volumeRatio":1.353486,"shares":9393514,"dividePrice":0,"high":7.3,"amplitude":0.082873,"preClose":7.24,"low":6.7,"week52Low":3.581,"pbRate":"1.94","week52High":14.21,"institutionHeld":0,"latestPrice":6.94,"committee":-0.960784,"eps":-23.01,"divideRate":0,"volume":46174,"delay":0,"ttmEps":-23.01,"open":7.1,"prevYearClose":7.57,"prevWeekClose":6.92,"prevMonthClose":7.92,"prevQuarterClose":9.19,"fiveDayClose":7.04,"twentyDayClose":8.17,"sixtyDayClose":8.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LONA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"LONA","fiscalQuarterEnding":"2026/06","expectedEps":-1.9,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2026-05-07","symbol":"LONA","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-1.73},{"market":"US","date":"2026-03-26","symbol":"LONA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"LONA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-1.68},{"market":"US","date":"2025-09-18","symbol":"LONA","defaultRemindTime":1758202200000,"type":"split","dateTimestamp":1758168000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LONA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LONA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785470400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LONA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LONA","date":"2026-09-15","current":-0.301608,"percent":0.982036,"low":-2.796591,"twenty":-1.182488,"median":-0.719318,"eighty":-0.556582,"high":-0.456913,"avg":-0.899462,"sd":0.47339,"marketCap":70379822},"quantilePoints":[{"date":"2026-01-16","current":-0.662315,"twenty":-0.686048,"median":-0.684271,"eighty":-0.675175,"marketCap":24984524},{"date":"2026-01-23","current":-1.56325,"twenty":-0.686675,"median":-0.673032,"eighty":-0.651338,"marketCap":58970481},{"date":"2026-01-30","current":-1.165659,"twenty":-1.344824,"median":-0.68793,"eighty":-0.65761,"marketCap":43972150},{"date":"2026-02-06","current":-1.185458,"twenty":-1.276038,"median":-1.158235,"eighty":-0.670888,"marketCap":44719023},{"date":"2026-02-13","current":-1.158234,"twenty":-1.22753,"median":-1.158234,"eighty":-0.684166,"marketCap":43692072},{"date":"2026-02-20","current":-1.368597,"twenty":-1.23248,"median":-1.158234,"eighty":-0.68542,"marketCap":51627598},{"date":"2026-02-27","current":-1.390871,"twenty":-1.374537,"median":-1.170609,"eighty":-0.765162,"marketCap":52467831},{"date":"2026-03-06","current":-1.329,"twenty":-1.392851,"median":-1.185458,"eighty":-1.076564,"marketCap":50133852},{"date":"2026-03-13","current":-1.856145,"twenty":-1.437398,"median":-1.225055,"eighty":-1.089928,"marketCap":70019347},{"date":"2026-03-20","current":-2.457536,"twenty":-1.517584,"median":-1.326525,"eighty":-1.109727,"marketCap":92705616},{"date":"2026-03-27","current":-2.395664,"twenty":-1.826942,"median":-1.36281,"eighty":-1.136951,"marketCap":90371637},{"date":"2026-04-02","current":-0.885775,"twenty":-1.710128,"median":-1.327762,"eighty":-1.074089,"marketCap":93545848},{"date":"2026-04-10","current":-0.848546,"twenty":-1.591335,"median":-1.23743,"eighty":-0.90876,"marketCap":89614123},{"date":"2026-04-17","current":-0.732027,"twenty":-1.56325,"median":-1.192883,"eighty":-0.852104,"marketCap":77308620},{"date":"2026-04-24","current":-0.766716,"twenty":-1.526988,"median":-1.173083,"eighty":-0.820084,"marketCap":80972090},{"date":"2026-05-01","current":-0.80941,"twenty":-1.479966,"median":-1.161946,"eighty":-0.806742,"marketCap":85480977},{"date":"2026-05-08","current":-0.877009,"twenty":-1.479232,"median":-1.15081,"eighty":-0.806742,"marketCap":92620048},{"date":"2026-05-15","current":-0.798435,"twenty":-1.470067,"median":-1.095125,"eighty":-0.784505,"marketCap":103328654},{"date":"2026-05-22","current":-0.730931,"twenty":-1.437893,"median":-1.038891,"eighty":-0.766716,"marketCap":94592685},{"date":"2026-05-29","current":-0.699719,"twenty":-1.435914,"median":-0.977518,"eighty":-0.742344,"marketCap":90553474},{"date":"2026-06-05","current":-0.624957,"twenty":-1.41958,"median":-0.881392,"eighty":-0.732312,"marketCap":80878155},{"date":"2026-06-12","current":-0.616247,"twenty":-1.397801,"median":-0.861888,"eighty":-0.723673,"marketCap":79750933},{"date":"2026-06-18","current":-0.597374,"twenty":-1.391861,"median":-0.852104,"eighty":-0.699139,"marketCap":77308620},{"date":"2026-06-26","current":-0.630764,"twenty":-1.383447,"median":-0.845878,"eighty":-0.684375,"marketCap":81629636},{"date":"2026-07-02","current":-0.608262,"twenty":-1.377507,"median":-0.836094,"eighty":-0.66996,"marketCap":78717647},{"date":"2026-07-10","current":-0.681573,"twenty":-1.373052,"median":-0.819033,"eighty":-0.654571,"marketCap":88205096},{"date":"2026-07-17","current":-0.566889,"twenty":-1.363967,"median":-0.812078,"eighty":-0.651338,"marketCap":73363344},{"date":"2026-07-24","current":-0.525515,"twenty":-1.345814,"median":-0.798435,"eighty":-0.635734,"marketCap":68009041},{"date":"2026-07-31","current":-0.529145,"twenty":-1.328505,"median":-0.788063,"eighty":-0.629457,"marketCap":68478717},{"date":"2026-08-07","current":-0.566889,"twenty":-1.323555,"median":-0.7765,"eighty":-0.623505,"marketCap":73363344},{"date":"2026-08-14","current":-0.571244,"twenty":-1.296827,"median":-0.749803,"eighty":-0.613488,"marketCap":73926955},{"date":"2026-08-21","current":-0.511329,"twenty":-1.23248,"median":-0.741811,"eighty":-0.606085,"marketCap":72330057},{"date":"2026-08-28","current":-0.525516,"twenty":-1.210206,"median":-0.735286,"eighty":-0.594326,"marketCap":74336921},{"date":"2026-09-04","current":-0.512861,"twenty":-1.197337,"median":-0.731479,"eighty":-0.571244,"marketCap":72546805},{"date":"2026-09-11","current":-0.456913,"twenty":-1.185458,"median":-0.727664,"eighty":-0.557453,"marketCap":64632608},{"date":"2026-09-15","current":-0.497542,"twenty":-1.182488,"median":-0.719318,"eighty":-0.556582,"marketCap":70379822}],"updateTime":1789584336242},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LONA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1103736186","title":"LeonaBio完成拉索昔芬聯合阿貝西利III期ELAIN-3試驗第500例受試者入組——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103736186","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103736186?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 04:40","pubTimestamp":1787776809,"startTime":"0","endTime":"0","summary":"LeonaBio宣布，其拉索昔芬联合阿贝西利方案的III期ELAIN-3临床试验已成功完成第500例受试者入组。这一里程碑式的进展已在最新提交给美国证券交易委员会（SEC）的文件中正式披露。\n值得关注的是，ELAIN-3试验旨在评估拉索昔芬与CDK4/6抑制剂阿贝西利联用的疗效与安全性。此次入组人数的突破，标志着该研究项目在推进过程中迈出了坚实的一步。通过SEC文件的公开信息，市场得以一窥这一关键节点的最新动态。\n业内观察人士认为，随着受试者招募工作的持续推进，该试验的数据积累正逐步走向成熟，未来有望为相关治疗领域提供更具说服力的循证依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LONA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124104746","title":"LeonaBio Inc預計Lasofoxifene三期試驗患者招募將於2026年第四季度完成，關鍵數據將於2027年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1124104746","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124104746?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 05:13","pubTimestamp":1774559590,"startTime":"0","endTime":"0","summary":"LeonaBio Inc宣布，其针对Lasofoxifene的三期临床试验预计将在2026年第四季度完成患者招募工作。该试验的关键数据结果计划于2027年下半年对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LONA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LONA\",params:#limit:6,delay:false,,,undefined,":[]}}